Irish specialty biopharmaceutical company Shire has appointed Jeff Jonas, MD, as president of Shire's regenerative medicine business.
After a varied career in R&D, commercial and entrepreneurial business roles, Jonas joined Shire in July 2008 as leader of the specialty pharmaceuticals R&D team. He has been closely involved with the regenerative medicine business since Shire acquired it as Advanced BioHealing in June 2011. In addition to his role as head of the specialty pharmaceuticals R&D team, Jonas has been leading the regenerative medicine R&D team and has been a member of the leadership team.
Before joining Shire in 2008, Jonas served as executive vice president at Isis Pharmaceuticals and before that, as chief medical officer and executive vice president at Forest Laboratories. Jonas began his career at Upjohn Laboratories where he advanced to the position of chief medical officer.